Matches in Nanopublications for { <http://rdf.disgenet.org/nanopublications.trig#NP717711.RAaeLJmnE2Z9uR8BlQWxNKVrCsd-BvCb0UYQWcuMb_FxI130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP717711.RAaeLJmnE2Z9uR8BlQWxNKVrCsd-BvCb0UYQWcuMb_FxI130_assertion type Assertion NP717711.RAaeLJmnE2Z9uR8BlQWxNKVrCsd-BvCb0UYQWcuMb_FxI130_head.
- NP717711.RAaeLJmnE2Z9uR8BlQWxNKVrCsd-BvCb0UYQWcuMb_FxI130_assertion wasGeneratedBy ECO_0000203 NP717711.RAaeLJmnE2Z9uR8BlQWxNKVrCsd-BvCb0UYQWcuMb_FxI130_provenance.
- NP717711.RAaeLJmnE2Z9uR8BlQWxNKVrCsd-BvCb0UYQWcuMb_FxI130_assertion wasDerivedFrom befree-20140225 NP717711.RAaeLJmnE2Z9uR8BlQWxNKVrCsd-BvCb0UYQWcuMb_FxI130_provenance.
- NP717711.RAaeLJmnE2Z9uR8BlQWxNKVrCsd-BvCb0UYQWcuMb_FxI130_assertion SIO_000772 18068703 NP717711.RAaeLJmnE2Z9uR8BlQWxNKVrCsd-BvCb0UYQWcuMb_FxI130_provenance.
- NP717711.RAaeLJmnE2Z9uR8BlQWxNKVrCsd-BvCb0UYQWcuMb_FxI130_assertion evidence source_evidence_literature NP717711.RAaeLJmnE2Z9uR8BlQWxNKVrCsd-BvCb0UYQWcuMb_FxI130_provenance.
- NP717711.RAaeLJmnE2Z9uR8BlQWxNKVrCsd-BvCb0UYQWcuMb_FxI130_assertion description "[The frequencies of cancer-related gene methylation were as follows: 89% for RASSF1A, 52% for NEUROG1, 5% for DAP-kinase, RUNX3 and CACNA1G, and 0 for RAR-beta2, SOCS-1 and IGF-2.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP717711.RAaeLJmnE2Z9uR8BlQWxNKVrCsd-BvCb0UYQWcuMb_FxI130_provenance.